April 4, 2019
Carl M. Wiese is a Founder and Portfolio Manager for GROW Funds LLC and has over 30 years of investment management experience. Mr. Wiese is an adjunct professor at the University of San Diego and the Education Chair for the CFA Society of San Diego.
Prior to launching GROW, Mr. Wiese was a Principal and Portfolio Manager at Wall Street Associates — $3 billion in AUM — where he was responsible for micro, small and midcap investment strategy and was a member of the investment management team for 12 years.
Michael Collins is a Founder and Portfolio Manager for GROW Funds LLC. Mr. Collins’ career has spanned over 50 years starting as an investment banker and the last 30 years as a registered investment adviser. He has been a founder of several companies and served on the boards of the National Association of Securities Dealers and the CFA Society of San Diego.
In this 2,251 word interview exclusive to the Wall Street Transcript, Mr. Collins and Mr. Wiese explain their portfolio management techniques and their top picks.
“I will get away from software here and talk about health care. Tandem Diabetes Care (NASDAQ:TNDM) is actually a local San Diego company. They develop and manufacture insulin pumps for diabetics. They have what we believe is the best pump in the market today called the t:slim X2 Basal-IQ.
It’s taking market share from Medtronic (NYSE:MDT), the largest provider in the marketplace. Not only that, Johnson & Johnson (NYSE:JNJ), their Animas division, recently exited the market, creating an opportunity for Tandem to take share with those patients as well.”
Another top pick reveals their growth bias:
“Telecommunications is a $50 billion market globally. RingCentral is taking market share from more traditional providers such as Avaya (NYSE:AVYA) and Cisco (NASDAQ:CSCO). In fact, after trying to do it themselves, AT&T (NYSE:T) recently came back to RingCentral as a partner.
RingCentral is growing revenues in the mid-30% range and has recently added customers such as Columbia University, the Financial Times and Golden State Warriors to name a few.”
Get more investing philosophy along with top stock picks by reading the entire 2,251 word interview, exclusive to the Wall Street Transcript.
This post was originally published on *this site*